Efficacy and safety of methotrexate, omalizumab and dupilumab for bullous pemphigoid in patients resistant or contraindicated to oral steroids. A monocentric real-life study.
M VelinP-M DugourdA SanchezP BahadoranHenri MontaudiéThierry PasseronPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)